Amil Patel
Co-Founder/CEO

Meeko Health provides FDA-approved ketamine-assisted therapy to treat mental health conditions such as depression and anxiety, offering rapid access to care through a network of licensed providers across the United States. This therapy has been shown to be five times more effective than traditional antidepressants, delivering significant improvements in emotional well-being within a few weeks.
Traditional treatments for mental health conditions like depression and anxiety can be lengthy and may not provide sufficient relief for many individuals. Access to effective mental healthcare can also be limited by long wait times and geographical constraints.
Meeko Health offers FDA-approved ketamine-assisted therapy as a rapid and effective treatment option for mental health conditions. By partnering with a network of licensed providers across the United States, Meeko Health provides quick access to care, often within days rather than weeks or months. Ketamine therapy can lead to significant improvements in emotional well-being in a shorter timeframe compared to traditional antidepressants, and can be combined with talk therapy for lasting results. Meeko Health aims to address the root causes of emotional trauma and mental health challenges, helping individuals and organizations thrive.
Meeko Health primarily targets individuals experiencing mental health conditions such as depression and anxiety, as well as employers seeking to provide comprehensive mental health benefits to their employees.